These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27252461)

  • 1. Identification and Antifungal Susceptibility Profile of Candida guilliermondii and Candida fermentati from a Multicenter Study in China.
    Cheng JW; Yu SY; Xiao M; Wang H; Kudinha T; Kong F; Xu YC
    J Clin Microbiol; 2016 Aug; 54(8):2187-9. PubMed ID: 27252461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features of patients with infections caused by Candida guilliermondii and Candida fermentati and antifungal susceptibility of the isolates at a medical centre in Taiwan, 2001-10.
    Chen CY; Huang SY; Tang JL; Tsay W; Yao M; Ko BS; Chou WC; Tien HF; Hsueh PR
    J Antimicrob Chemother; 2013 Nov; 68(11):2632-5. PubMed ID: 23766486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and Susceptibility Profile of Candida fermentati from a worldwide collection of Candida guilliermondii clinical isolates.
    Lockhart SR; Messer SA; Pfaller MA; Diekema DJ
    J Clin Microbiol; 2009 Jan; 47(1):242-4. PubMed ID: 19036938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Microbiological Characteristics of Candida guilliermondii and Candida fermentati.
    Hirayama T; Miyazaki T; Yamagishi Y; Mikamo H; Ueda T; Nakajima K; Takesue Y; Higashi Y; Yamamoto Y; Kimura M; Araoka H; Taniguchi S; Fukuda Y; Matsuo Y; Furutani A; Yamashita K; Takazono T; Saijo T; Shimamura S; Yamamoto K; Imamura Y; Izumikawa K; Yanagihara K; Kohno S; Mukae H
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29581115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reidentification and antifungal susceptibility profile of Candida guilliermondii and Candida famata clinical isolates from a culture collection in Argentina.
    Taverna CG; Córdoba S; Vivot M; Szusz W; Vivot W; Bosco-Borgeat ME; Davel G
    Med Mycol; 2019 Apr; 57(3):314-323. PubMed ID: 29955881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Trend of susceptibility testing of clinical isolates of Candida species from aseptic samples in hospitals in Saitama prefecture].
    Tarumoto N; Watanabe N; Tanabe K; Hashikita G; Takahashi S; Yuki A; Hirose Y; Sekine S; Kanoh I; Shimojima M; Kaneda M; Yamaguchi T; Ohno H; Miyazaki Y; Maesaki S
    Jpn J Antibiot; 2014 Aug; 67(4):215-21. PubMed ID: 25420317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida auris Clinical Isolates from South Korea: Identification, Antifungal Susceptibility, and Genotyping.
    Kwon YJ; Shin JH; Byun SA; Choi MJ; Won EJ; Lee D; Lee SY; Chun S; Lee JH; Choi HJ; Kee SJ; Kim SH; Shin MG
    J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30728190
    [No Abstract]   [Full Text] [Related]  

  • 8. Candida Species From Eye Infections: Drug Susceptibility, Virulence Factors, and Molecular Characterization.
    Ranjith K; Sontam B; Sharma S; Joseph J; Chathoth KN; Sama KC; Murthy SI; Shivaji S
    Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):4201-4209. PubMed ID: 28837732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of serum on in vitro susceptibility testing of echinocandins for Candida parapsilosis and Candida guilliermondii.
    Saribas Z; Yurdakul P; Cetin-Hazirolan G; Arikan-Akdagli S
    Mycoses; 2012 Mar; 55(2):156-60. PubMed ID: 21668525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
    Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
    J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method.
    Kathuria S; Singh PK; Sharma C; Prakash A; Masih A; Kumar A; Meis JF; Chowdhary A
    J Clin Microbiol; 2015 Jun; 53(6):1823-30. PubMed ID: 25809970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis.
    Pinto PM; Weikert-Oliveira Rde C; Lyon JP; Cury VF; Arantes RR; Koga-Ito CY; Resende MA
    Microbiol Res; 2008; 163(5):579-85. PubMed ID: 16962755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Antifungal Susceptibility Profiles of Candida haemulonii Species Complex Clinical Isolates from a Multicenter Study in China.
    Hou X; Xiao M; Chen SC; Wang H; Cheng JW; Chen XX; Xu ZP; Fan X; Kong F; Xu YC
    J Clin Microbiol; 2016 Nov; 54(11):2676-2680. PubMed ID: 27535688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal susceptibility of 1000 Candida bloodstream isolates to 5 antifungal drugs: results of a multicenter study conducted in São Paulo, Brazil, 1995-2003.
    da Matta DA; de Almeida LP; Machado AM; Azevedo AC; Kusano EJ; Travassos NF; Salomão R; Colombo AL
    Diagn Microbiol Infect Dis; 2007 Apr; 57(4):399-404. PubMed ID: 17240110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Species distribution and antifungal susceptibility of Candida spp. isolated from superficial candidiasis in outpatients in Iran.
    Razzaghi-Abyaneh M; Sadeghi G; Zeinali E; Alirezaee M; Shams-Ghahfarokhi M; Amani A; Mirahmadi R; Tolouei R
    J Mycol Med; 2014 Jun; 24(2):e43-50. PubMed ID: 24767256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of caspofungin against Candida guilliermondii and Candida parapsilosis.
    Barchiesi F; Spreghini E; Tomassetti S; Della Vittoria A; Arzeni D; Manso E; Scalise G
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2719-27. PubMed ID: 16870764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study.
    Schmalreck AF; Willinger B; Haase G; Blum G; Lass-Flörl C; Fegeler W; Becker K;
    Mycoses; 2012 May; 55(3):e124-37. PubMed ID: 22233267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and susceptibility testing of Candida spp. directly from yeast-positive blood cultures with Vitek 2.
    González-Lara MF; Torres-González P; Rangel-Cordero A; Sifuentes-Osornio J; Ponce-de-León A; Martínez-Gamboa A
    Diagn Microbiol Infect Dis; 2017 Nov; 89(3):202-204. PubMed ID: 28818396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005.
    Pfaller MA; Diekema DJ; Gibbs DL; Newell VA; Ng KP; Colombo A; Finquelievich J; Barnes R; Wadula J;
    J Clin Microbiol; 2008 Mar; 46(3):842-9. PubMed ID: 18199791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.